Suppr超能文献

血清肌酐升高后停用血管紧张素转换酶抑制剂的发生率及预测因素:一项回顾性队列研究。

Rates and predictors of ACE inhibitor discontinuation subsequent to elevated serum creatinine: a retrospective cohort study.

作者信息

Jackevicius Cynthia A, Wong Joyce, Aroustamian Irina, Gee Manyee, Mody Freny Vaghaiwalla

出版信息

BMJ Open. 2014;4(8):e005181. doi: 10.1136/bmjopen-2014-005181.

Abstract

OBJECTIVES

ACE inhibitors (ACEI) are underutilised despite cardiovascular benefits, in part due to concerns of known transient elevations in serum creatinine (SCr) after initiation. Our objectives were to evaluate rates and predictors of ACEI discontinuation after SCr elevation post-ACEI initiation since limited data are available that examine this issue.

SETTING

Primary and tertiary Veterans healthcare system in Los Angeles, California, USA PARTICIPANTS: 3039 outpatients initiating an ACEI with a SCr measured within 6 months prior to and approximately 3 months after initiating an ACEI. Patients were divided into three groups (SCr <1.5, 1.5–2 and >2).

PRIMARY AND SECONDARY OUTCOME MEASURES

Rates and factors associated with ACEI discontinuation subsequent to SCr elevation after ACEI initiation and for patients with baseline SCr >2 mg/dL, the change in SCr associated with chronic use. Predictors were identified using multivariate logistic regression modelling.

RESULTS

At 3 months follow-up, for those with an increase in SCr, the mean increase post-ACEI initiation was 26%, ranging from −0.01 mg/dL to 0.42 mg/dL varying according to a level of baseline renal function. ACEI discontinuation was higher in patients with elevated baseline SCr (19/165, 11.5%) compared with those with SCr <1.5 (135/2497, 5.4%), and those with SCr 1.5–2.0 (28/377, 7.4%). Male patients, and those with heart failure were less likely to discontinue ACEI after an elevation of SCr post-ACEI initiation, while those taking non-steroidal anti-inflammatory drugs, diuretics and β-blockers were more likely to discontinue ACEI.

CONCLUSIONS

SCr increases <30% on average within 3 months of ACEI initiation, with subsequent discontinuation rates varying by baseline SCr. Elevation in SCr was not associated with ACEI discontinuation rates. In patients with SCr >2 mg/dL at baseline, despite an acute increase in SCr after ACEI initiation, chronic ACEI use was associated with a decrease in SCr in most patients.

摘要

目的

尽管血管紧张素转换酶抑制剂(ACEI)具有心血管益处,但仍未得到充分利用,部分原因是人们担心开始使用后血清肌酐(SCr)会出现已知的短暂升高。我们的目的是评估ACEI开始使用后SCr升高后ACEI停药的发生率和预测因素,因为目前关于这一问题的研究数据有限。

背景

美国加利福尼亚州洛杉矶的初级和三级退伍军人医疗系统

参与者

3039名门诊患者开始使用ACEI,在开始使用ACEI前6个月内及开始使用后约3个月测量SCr。患者分为三组(SCr<1.5、1.5 - 2和>2)。

主要和次要结局指标

ACEI开始使用后SCr升高后与ACEI停药相关的发生率和因素,对于基线SCr>2mg/dL的患者,与长期使用相关的SCr变化。使用多因素逻辑回归模型确定预测因素。

结果

在3个月的随访中,对于SCr升高的患者,ACEI开始使用后平均升高26%,根据基线肾功能水平,范围从-0.01mg/dL到0.42mg/dL不等。与SCr<1.5的患者(135/2497,5.4%)和SCr为1.5 - 2.0的患者(28/377,7.4%)相比,基线SCr升高的患者中ACEI停药率更高(19/165,11.5%)。男性患者以及心力衰竭患者在ACEI开始使用后SCr升高后停药的可能性较小,而服用非甾体抗炎药、利尿剂和β受体阻滞剂的患者停药的可能性较大。

结论

ACEI开始使用后3个月内SCr平均升高<30%,随后停药率因基线SCr而异。SCr升高与ACEI停药率无关。对于基线SCr>2mg/dL的患者,尽管ACEI开始使用后SCr急性升高,但大多数患者长期使用ACEI与SCr降低相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6dc/4139635/7b5529ada390/bmjopen2014005181f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验